147 related articles for article (PubMed ID: 18565219)
1. Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells.
Kalayda GV; Wagner CH; Buss I; Reedijk J; Jaehde U
BMC Cancer; 2008 Jun; 8():175. PubMed ID: 18565219
[TBL] [Abstract][Full Text] [Related]
2. Comparative features of copper ATPases ATP7A and ATP7B heterologously expressed in COS-1 cells.
Liu Y; Pilankatta R; Hatori Y; Lewis D; Inesi G
Biochemistry; 2010 Nov; 49(46):10006-12. PubMed ID: 20964302
[TBL] [Abstract][Full Text] [Related]
3. Translocation of platinum anticancer drugs by human copper ATPases ATP7A and ATP7B.
Tadini-Buoninsegni F; Bartolommei G; Moncelli MR; Inesi G; Galliani A; Sinisi M; Losacco M; Natile G; Arnesano F
Angew Chem Int Ed Engl; 2014 Jan; 53(5):1297-301. PubMed ID: 24375922
[TBL] [Abstract][Full Text] [Related]
4. Cell-specific ATP7A transport sustains copper-dependent tyrosinase activity in melanosomes.
Setty SR; Tenza D; Sviderskaya EV; Bennett DC; Raposo G; Marks MS
Nature; 2008 Aug; 454(7208):1142-6. PubMed ID: 18650808
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic basis for overcoming platinum resistance using copper chelating agents.
Liang ZD; Long Y; Tsai WB; Fu S; Kurzrock R; Gagea-Iurascu M; Zhang F; Chen HH; Hennessy BT; Mills GB; Savaraj N; Kuo MT
Mol Cancer Ther; 2012 Nov; 11(11):2483-94. PubMed ID: 22914438
[TBL] [Abstract][Full Text] [Related]
6. ATPase Copper Transporting Beta (ATP7B) Is a Novel Target for Improving the Therapeutic Efficacy of Docetaxel by Disulfiram/Copper in Human Prostate Cancer.
Song L; Nguyen V; Xie J; Jia S; Chang CJ; Uchio E; Zi X
Mol Cancer Ther; 2024 Jun; 23(6):854-863. PubMed ID: 38417139
[TBL] [Abstract][Full Text] [Related]
7. ATP7B expression in human breast epithelial cells is mediated by lactational hormones.
Michalczyk A; Bastow E; Greenough M; Camakaris J; Freestone D; Taylor P; Linder M; Mercer J; Ackland ML
J Histochem Cytochem; 2008 Apr; 56(4):389-99. PubMed ID: 18180385
[TBL] [Abstract][Full Text] [Related]
8. Gli1 contributes to cellular resistance to cisplatin through altered cellular accumulation of the drug.
Amable L; Fain J; Gavin E; Reed E
Oncol Rep; 2014 Aug; 32(2):469-74. PubMed ID: 24926795
[TBL] [Abstract][Full Text] [Related]
9. COMMD1 is linked to the WASH complex and regulates endosomal trafficking of the copper transporter ATP7A.
Phillips-Krawczak CA; Singla A; Starokadomskyy P; Deng Z; Osborne DG; Li H; Dick CJ; Gomez TS; Koenecke M; Zhang JS; Dai H; Sifuentes-Dominguez LF; Geng LN; Kaufmann SH; Hein MY; Wallis M; McGaughran J; Gecz J; Sluis Bv; Billadeau DD; Burstein E
Mol Biol Cell; 2015 Jan; 26(1):91-103. PubMed ID: 25355947
[TBL] [Abstract][Full Text] [Related]
10. Structure and mechanism of the human copper transporting ATPases: Fitting the pieces into a moving puzzle.
Dmitriev OY; Patry J
Biochim Biophys Acta Biomembr; 2024 Apr; 1866(4):184306. PubMed ID: 38408697
[TBL] [Abstract][Full Text] [Related]
11. Role of the P-Type ATPases, ATP7A and ATP7B in brain copper homeostasis.
Telianidis J; Hung YH; Materia S; Fontaine SL
Front Aging Neurosci; 2013; 5():44. PubMed ID: 23986700
[TBL] [Abstract][Full Text] [Related]
12. ATPase copper transporter A, negatively regulated by miR-148a-3p, contributes to cisplatin resistance in breast cancer cells.
Yu Z; Cao W; Ren Y; Zhang Q; Liu J
Clin Transl Med; 2020 Jan; 10(1):57-73. PubMed ID: 32508020
[TBL] [Abstract][Full Text] [Related]
13. Pre-Treatment of platinum resistant ovarian cancer cells with an MMP-9/MMP-2 inhibitor prior to cisplatin enhances cytotoxicity as determined by high content screening.
Laios A; Mohamed BM; Kelly L; Flavin R; Finn S; McEvoy L; Gallagher M; Martin C; Sheils O; Ring M; Davies A; Lawson M; Gleeson N; D'Arcy T; d'Adhemar C; Norris L; Langhe R; Saadeh FA; O'Leary JJ; O'Toole SA
Int J Mol Sci; 2013 Jan; 14(1):2085-103. PubMed ID: 23340649
[TBL] [Abstract][Full Text] [Related]
14. Integrin αV control of Cu homeostasis and cisplatin sensitivity.
Lin X; Shang X; Howell SB
Cell Cycle; 2014; 13(21):3317-8. PubMed ID: 25485574
[No Abstract] [Full Text] [Related]
15. Cellular copper distribution: a mechanistic systems biology approach.
Banci L; Bertini I; Cantini F; Ciofi-Baffoni S
Cell Mol Life Sci; 2010 Aug; 67(15):2563-89. PubMed ID: 20333435
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms associated with cuproptosis and implications for ovarian cancer.
Chen B; Liu J
J Inorg Biochem; 2024 Aug; 257():112578. PubMed ID: 38797108
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of copper-associated and oxidative stress related proteins in a new variant of copper toxicosis in Doberman pinschers.
Spee B; Mandigers PJ; Arends B; Bode P; van den Ingh TS; Hoffmann G; Rothuizen J; Penning LC
Comp Hepatol; 2005 Mar; 4(1):3. PubMed ID: 15790412
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of cisplatin resistance.
Galluzzi L; Senovilla L; Vitale I; Michels J; Martins I; Kepp O; Castedo M; Kroemer G
Oncogene; 2012 Apr; 31(15):1869-83. PubMed ID: 21892204
[TBL] [Abstract][Full Text] [Related]
19. SPG21, a potential oncogene targeted by miR-128-3p, amplifies HBx-induced carcinogenesis and chemoresistance via activation of TRPM7-mediated JNK pathway in hepatocellular carcinoma.
Zhou P; Yao W; Liu L; Yan Q; Chen X; Wei X; Ding S; Lv Z; Zhu F
Cell Oncol (Dordr); 2024 May; ():. PubMed ID: 38753154
[TBL] [Abstract][Full Text] [Related]
20. The Antineoplastic Effect of Carboplatin Is Potentiated by Combination with Pitavastatin or Metformin in a Chemoresistant High-Grade Serous Carcinoma Cell Line.
Nunes M; Duarte D; Vale N; Ricardo S
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
